Figure 2
From: Prognosis of AKI in malignant diseases with and without sepsis
Incidence of AKI and mortality in tumor versus non-tumor patients. Incidences of AKI were: patients without malignancy 329/805 (41%), patients with a malignant disease (either solid or non-solid tumor) 104/212 (49%). The difference was statistically significant (p=0.032). Mortalty rates were: patients without tumor but with AKI 93/329 (28%), patients with malignancy and AKI 53/104 (51%). The calculated p-value was below 0.001.